CARsgen Therapeutics Holdings Limited announced that its board of directors will convene on 18 August 2026 to review and approve the Group’s interim results for the six months ended 30 June 2026, and to address other business matters.

The board currently comprises: • Executive Directors: Dr. Zonghai Li (Chairman), Dr. Huamao Wang and Dr. Hua Jiang • Non-executive Directors: Mr. Huaqing Guo and Mr. Ronggang Xie • Independent Non-executive Directors: Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou

The announcement was signed by Chairman Dr. Zonghai Li and dated 6 August 2026 in Hong Kong.